Can the E-2 be a basis for a biotechnology startup?

The E-2 visa is an option for investors who wish to establish businesses in the United States, provided that the investor’s country of origin has a trade treaty with the USA. It is an instrument that requires the investor to make a substantial investment and that the business be operational, with real risks and potential to contribute to the local economy.

When it comes to a biotechnology startup, the E-2 can indeed be a viable basis – provided that all requirements demanded for this visa are met. It is essential that the company presents a detailed business plan, with financial projections, a clear strategy for development, and a demonstration that it is, or will be, in full operation.

In the case of biotechnology, which often involves significant investments in research and development, it will be necessary to prove how this invested capital generates value and the inherent risks of the business. Another important point is that the investment must be considered ‘substantial’ in relation to the total cost of setting up the business.

Therefore, for startups in innovative fields such as biotechnology, it is essential to demonstrate that the financial contribution is not symbolic but rather capable of ensuring the viability and operational continuity of the enterprise.

It is worth highlighting that strictly following United States immigration laws is imperative. I always recommend seeking guidance from specialized sources and avoiding reliance on unfounded promises or marketing campaigns guaranteeing results. Be wary of offers that seem too good to be true and make sure all documentation complies with legal requirements before making any decision.

In summary, although the E-2 can be used as a basis for creating a biotechnology startup, the success of the process will depend on a careful analysis of the investment, the business plan, and compliance with all criteria established by US legislation. Seeking information from reliable sources and thoroughly learning about the process is always the best path to avoid future setbacks.

Victoria Harper

Editor-in-Chief

Meet the author

Leading journalism and editorial content at Visto n’ Visa, Victoria helps make immigration topics clear, trustworthy, and easy to understand. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.